Reporting Serious Adverse Events for Generic Drugs: Procedures, Gaps, and Fixes
Explore the procedures for reporting serious adverse events for generic drugs, highlighting the data gaps between brand and generic medications and new regulatory fixes.
Explore the procedures for reporting serious adverse events for generic drugs, highlighting the data gaps between brand and generic medications and new regulatory fixes.
Discover if generic drugs are truly equivalent to brand-name medications. We explore bioequivalence, cost savings, inactive ingredients, and when you might need to stick with the brand.
Hospital formularies select generic drugs through evidence-based reviews by Pharmacy and Therapeutics committees, balancing clinical effectiveness, safety, and cost. Learn how these systems ensure quality care while cutting expenses.
Generic drugs save billions in healthcare costs worldwide. Discover the key trends shaping their future - from biosimilars and supply chain risks to India’s manufacturing boom and growing demand in emerging markets.